Skip to content
2000
Volume 4, Issue 1
  • ISSN: 2666-7967
  • E-ISSN: 2666-7975

Abstract

Australia finally permitted in July 2022 the use of oral antivirals against COVID-19. For the previous 2.5 years, the local bureaucrats have prevented medical doctors to prescribe the antivirals successfully used in other jurisdictions. Suddenly, they changed their mind, even if the opening of the restrictions was limited to only two products not known to be the most effective, nor the cheapest, in between the many available.

Loading

Article metrics loading...

/content/journals/covid/10.2174/2666796704666230228105723
2023-02-01
2025-10-14
Loading full text...

Full text loading...

/content/journals/covid/10.2174/2666796704666230228105723
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test